Nektar Therapeutics (NKTR) Discusses 36-Week Maintenance Results From Phase 2b REZOLVE-AD Study in Atopic Dermatitis – Slideshow

Trending

• Tech7 days ago

  Wikipedia volunteers spent years cataloging AI tells. Now there’s a plugin to avoid them.

• Politics2 days ago

  Why Israel is blocking foreign journalists from entering

• NewsBeat1 day ago

  Mia Brookes misses out on Winter Olympics medal in snowboard big air

• Sports4 days ago

  JD Vance booed as Team USA enters Winter Olympics opening ceremony

• Tech4 days ago

  First multi-coronavirus vaccine enters human testing, built on UW Medicine technology

• Business2 days ago

  LLP registrations cross 10,000 mark for first time in Jan